Pharmaceutical Sector Archives - Institute for Mergers, Acquisitions and Alliances (IMAA)

Pharma M&A: Agile Shouldn’t Mean Ad Hoc

By Ankur Agrawal, Ruth De Backer, Spring Liu – McKinsey & Company Contributors: Alvaro Aguero, Matthew Van Wingerden Under pressure to be active acquirers, some pharmaceutical and...

Deal Tectonics: At The Fault Line Of Growth Goals And Competitive Pressures

EY’s Firepower Index and Growth Gap Report 2016 By Andrew Forman – Ernst & Young Contributors: Jeff Greene, Chris Morrison As the specialty pharmaceutical sector sees its ability to pursue...

When Do Acquirers Invest In The R&D Assets Of Acquired Science-Based Firms In Cross-Border Acquisitions?

The Role of Technology and Capabilities Similarity and Complementarity By Marcela Miozzo, Lori DiVito, Panos Desyllas Drawing on a multiple case study of acquisitions of UK biopharmaceutical firms,...

Approach To The Issues Of Leadership In The Processes Of Companies’ Acquisitions

6th International Conference on Applied Human Factors and Ergonomics (AHFE 2015) and the Affiliated Conferences, AHFE 2015 By Anna Stankiewicz-Mróz Abstract This paper presents the results of the...

Dealing With Uncertainty: Strategies For Overcoming Compliance Risk And Regulatory Challenges In Cross-Border M&A

Pharmerging markets report By Baker & McKenzie Introduction When you look at the numbers, there’s no question why global pharmaceutical companies have set their sights on emerging markets for...

Loading.. Please wait